| Patents for C07K 1 - General processes for the preparation of peptides (51,718) |
|---|
| 03/08/2007 | US20070053925 Staphylococcus aureus efb protein and c3 binding region which inhibit complement activation |
| 03/08/2007 | US20070051626 Cataphoresis apparatus cataphoresis method, and detection method for organism-related material using the apparatus and the method |
| 03/08/2007 | CA2620624A1 Method for generating anti-variable region monoclonal antibodies |
| 03/07/2007 | EP1760149A1 Method of constructing modified protein |
| 03/07/2007 | EP1759212A1 Identification of compounds modifying a cellular response |
| 03/07/2007 | EP1759186A2 Sensor constructs and detection methods |
| 03/07/2007 | EP1758937A2 Stable protein storage and stable nucleic acid storage in recoverable form |
| 03/07/2007 | EP1758927A2 Amidated parathyroid hormone fragments and uses thereof |
| 03/07/2007 | EP1758677A2 Peptide purification by means of hard metal ion affinity chromatography |
| 03/07/2007 | EP1547451A4 Cell adhesion resisting surfaces |
| 03/07/2007 | EP1414307B1 Method of enhancing the extraction of proteinase inhibitors |
| 03/07/2007 | EP1397372A4 Water-soluble polymeric metal ion affinity compositions and methods for using the same |
| 03/07/2007 | EP1395283B1 Heterologous protection induced by immunization with invaplex vaccine |
| 03/07/2007 | EP1313849B8 Methods of enucleating a cell |
| 03/07/2007 | EP1261622B1 Purified recombinant hlh having a specific bioactivity and process for purification thereof |
| 03/07/2007 | EP1212356B1 Protein structures and protein fibres |
| 03/07/2007 | EP1001970B1 Dipeptide derivatives as growth hormone secretagogues |
| 03/07/2007 | CN1926150A Method for the purification of an N-terminal fragment of hepatocyte growth factor |
| 03/07/2007 | CN1926146A Antibody purification |
| 03/07/2007 | CN1925898A Antibody purification technique |
| 03/07/2007 | CN1924001A Method of producing human heat shock protein 70 from methyl nutritious yeast |
| 03/07/2007 | CN1923864A Preparation technology of aminated macromolecule microsphere and application thereof |
| 03/07/2007 | CN1923851A Preparation method of synthesizing growth chalone from solid phase polypeptide |
| 03/07/2007 | CN1923848A Melon seed polypeptide |
| 03/07/2007 | CN1923847A Linear valve-coupled two-dimensional separation device and separation matrix and method |
| 03/07/2007 | CN1923357A Selective adsorbent low density lipoprotein cholesterol and method for preparing same |
| 03/07/2007 | CN1303413C Protein and virus quick-speed concentration method |
| 03/07/2007 | CN1303207C Renaturation separation purification method of tissue plasminogen activator mutant |
| 03/07/2007 | CN1303104C Method for extracting protease A inhibitor and its application |
| 03/07/2007 | CN1303100C Method for preliminary purification of recombinant human parathormone fusion protein by thermo osmosis shock technology |
| 03/07/2007 | CN1303099C Ganoderma tsugae-proteoglycan mixture and its preparing method and use |
| 03/06/2007 | US7186855 Such as 1-(((alpha-propanoyloxybutoxy)carbonyl)aminomethyl)-1-cyclohexane acetic acid; ability to cross blood brain barrier; sustained release |
| 03/06/2007 | US7186811 Preparing a bone morphogenetic protein complex by extraction with guanidine hydrochloride, concentration with ultrafiltration, dialysis, high pressure liquid chromatography gel filtration into three fractions, and drying and sterilization of the first fraction; storage stability |
| 03/06/2007 | US7186810 Modified peptides as therapeutic agents |
| 03/06/2007 | US7186802 Membrane proteins; for treatment of inflammation, asthma, allergy, metastasis of cancer cells, ion transport disorders such as magnesium defects in the kidney, and inflammatory bowel disease |
| 03/06/2007 | US7186797 Stability in blood ; complexing using compound containing phosphate group |
| 03/06/2007 | US7186697 Delivery system contains a fusion protein having a target moiety and a nucleic acid binding moiety, and a nucleic acid sequence bound to the nucleic acid binding moiety of the fusion protein. The target moiety can be an antibody or a |
| 03/06/2007 | US7186690 Method for attaching two surfaces to each other using a bioadhesive polyphenolic protein and periodate ions |
| 03/06/2007 | US7186688 Methods of stimulating angiogenesis in a patient by administering vascular endothelial growth factor 2 |
| 03/06/2007 | US7186684 Hemostatic device containing a protein precipitate |
| 03/06/2007 | US7186568 Electrochemiluminescence from acridan compounds |
| 03/06/2007 | US7186535 To act on reducing partial starch hydrolysates to produce non-reducing saccharides, and collecting the non-reducing saccharides or saccharide |
| 03/01/2007 | WO2007023915A1 Imprint polymer and use thereof |
| 03/01/2007 | WO2007023816A1 Method for preparation of reduced keratin, reduced cuticle protein or mixture thereof |
| 03/01/2007 | WO2007023811A1 Process for producing heavy atom derivative using vaporized iodine, method for collecting phase information, and method for determining three-dimensional structure of protein crystal |
| 03/01/2007 | WO2007023178A1 Prion inactivation |
| 03/01/2007 | WO2007022799A1 Process for the preparation of glycosylated interferon beta |
| 03/01/2007 | WO2007008071A3 Method for detecting peptides comprising a cross-beta structure |
| 03/01/2007 | WO2007005389A9 F11 receptor (f11r) antagonists as therapeutic agents |
| 03/01/2007 | WO2006081259A3 Gna1870-based vesicle vaccines for broad spectrum protection against diseases caused by neisseria meningitidis |
| 03/01/2007 | WO2006014498A3 Universal antibody libraries |
| 03/01/2007 | WO2005030711A3 Bridged macrocyclic module compositions |
| 03/01/2007 | US20070049741 For condensing DNA; ion exchanging |
| 03/01/2007 | US20070049731 Rapid Isolation of Osteoinductive Protein Mixtures from Mammalian Bone Tissue |
| 03/01/2007 | US20070049728 Solid phase synthesis supports and methods |
| 03/01/2007 | US20070049519 Bactericides with antibacterial activity and an improved mammalian safety profile; exhibit reduced tissue accumulation and/or nephrotoxicity when administered to mammals |
| 03/01/2007 | US20070048837 Site specific protein modification |
| 03/01/2007 | US20070048800 Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications |
| 03/01/2007 | US20070048786 Systems and methods for fractionation of protein mixtures |
| 03/01/2007 | US20070045115 Dual electrode injection of analyte into a capillary electrophoretic device |
| 03/01/2007 | CA2794554A1 Process for preparing antibody maytansinoid conjugates |
| 03/01/2007 | CA2620047A1 Prion inactivation |
| 03/01/2007 | CA2615560A1 Compositions and methods to control angiogenesis with cupredoxins |
| 02/28/2007 | EP1757695A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757694A2 Prostate-specific membrane antigen |
| 02/28/2007 | EP1757688A1 Method of disulfide crosslink forming type in vitro protein synthesis |
| 02/28/2007 | EP1757568A1 Method of labeling with isotope of oxygen |
| 02/28/2007 | EP1756579A2 Collections of traceable compounds and uses thereof |
| 02/28/2007 | EP1756318A2 Aptamer-toxin molecules and method for using same |
| 02/28/2007 | EP1756277A2 Quasirandom structure and function guided synthesis methods |
| 02/28/2007 | EP1756270A2 Diagnosis and treatment of myeloid and lymphoid cell cancers |
| 02/28/2007 | EP1756155A2 PURIFIED INTERLEUKIN-15/Fc FUSION PROTEIN AND PREPARATION THEREOF |
| 02/28/2007 | EP1756141A1 Process for the preparation of peptides |
| 02/28/2007 | EP1756128A1 Phosphonium salts derivatives and their use as solubility controlling auxiliaries |
| 02/28/2007 | EP1664085A4 Detecting molecules |
| 02/28/2007 | EP1578778A4 Ghrelin analogs |
| 02/28/2007 | EP1487762B1 Radiofluorination methods |
| 02/28/2007 | EP1027379B1 Method for producing polymeric solid phase supporting materials |
| 02/28/2007 | CN1922310A Methods for separating molecules |
| 02/28/2007 | CN1922201A A process for the preparation and purification of recombinant proteins |
| 02/28/2007 | CN1920055A Microelectronic system and apparatus capable of self-addressing and self-assembling for molecular biological analysis and diagnosis |
| 02/28/2007 | CN1919864A Preparation method of high purity serum gonadotrophin |
| 02/28/2007 | CN1919343A Boactivity peptide gene therapy method realized by propeptide recombination |
| 02/28/2007 | CN1302009C Technology of preparing rat nerve growth factor using organic solvent virus deactivation method |
| 02/28/2007 | CN1302006C Recombinant bovine thrombin |
| 02/27/2007 | US7183399 Nucleotide sequences coding reef coral fluorescent proteins for use as diagnostic tool in genetic engineering |
| 02/27/2007 | US7183392 Site-specific, covalent bioconjugation of proteins |
| 02/27/2007 | US7183381 Composition of lactoferrin related peptides and uses thereof |
| 02/27/2007 | US7183379 Human leucine-rich repeat containing protein expressed predominately in small intestine, HLRRSI1 |
| 02/27/2007 | US7183378 Bringing about refolding of protein wherein solution or suspension of protein is subjected to low intensity sound waves at frequency above 10 kHz and below 1 MHz, at low enough intensity that protein is not denatured, intensity being less than that at which sonocavitation occurs |
| 02/27/2007 | US7183067 Versatile linker compound, ligand, and producing method thereof |
| 02/27/2007 | US7183062 Prostaglandin receptor protein and methods of use thereof |
| 02/27/2007 | US7183059 Selecting desired synthetic precursors having defined stereochemical relationships, reacting precursors to obtain compound having specific stereochemistry, repeating selecting and reacting until desired library is obtained |
| 02/27/2007 | US7183002 That selectively bind molecules of interest, especially nucleic acid molecules, under appropriate conditions. Methods of that selectively bind molecules of interest, especially nucleic acid molecules, under appropriate conditions. |
| 02/27/2007 | US7182962 Swine plasma albumin; gene expression of immunostimulant; prevent infections; anticancer agents |
| 02/27/2007 | US7182945 End group acylation; genetic engineering; rheumatic diseases, respiratory system disorders |
| 02/27/2007 | CA2218620C Synthesis of proteins by native chemical ligation |
| 02/22/2007 | WO2007022012A2 Differentially protected orthogonal lanthionine technology |
| 02/22/2007 | WO2007021016A1 Photoregulated peptide, and method for regulation of peptide-protein complex formation using the photoregulated peptide |
| 02/22/2007 | WO2007020889A1 Novel mucin glycoprotein and use thereof |